Concomitant Mutations in EGFR 19Del/L858R Mutation and Their Association with Response to EGFR-TKIs in NSCLC Patients

OBJECTIVE: Differences in efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI) have been observed between non-small cell lung cancer (NSCLC) patients with 19 exon deletion (19Del) and L858R mutation. We explored whether the total number or pattern of concomitant mutatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Hengrui, Li, Caichen, Zhao, Yi, Zhao, Shen, Huang, Jun, Cai, Xiuyu, Cheng, Bo, Xiong, Shan, Li, Jianfu, Wang, Wei, Zhu, Changbin, Li, Weiwei, He, Jianxing, Liang, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509478/
https://www.ncbi.nlm.nih.gov/pubmed/32982456
http://dx.doi.org/10.2147/CMAR.S255967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509478/
https://www.ncbi.nlm.nih.gov/pubmed/32982456
http://dx.doi.org/10.2147/CMAR.S255967

Ejemplares similares